CSBR:NASDAQ
Champions Oncology Inc
4,79 US$
arrow_upward
+0,63%(+0,030) 1D
6 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,78 US$
High
4,87 US$
Low
4,75 US$
Mkt. cap
66,67 მლნ.
Avg. vol.
9,42 ათ.
Volume
4,25 ათ.
52-wk high
8,31 US$
52-wk low
4,59 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,78 US$
High
4,87 US$
Low
4,75 US$
Mkt. cap
66,67 მლნ.
Avg. vol.
9,42 ათ.
Volume
4,25 ათ.
52-wk high
8,31 US$
52-wk low
4,59 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
Zacks
·
13 საათის წინ
Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?
TradingView
·
14 საათის წინ
Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com